LabConnect, a provider of central laboratory services to the clinical trial industry, appointed former Quintiles executive Frank Morrow, Ph.D., as its chief operating officer.

Morrow was founding executive, president and chief scientific officer at Quintiles Laboratories Worldwide before joining LabConnect. According to LabConnect, he was responsible for growing Quintiles’ lab from inception to $120 million in revenue, 1,000 employees and five worldwide central lab facilities.

Elsewhere in the clinical trial industry, ICON named Alan Marion, M.D., Ph.D., vice president and medical director of the contract research organization’s (CRO’s) new clinical pharmacology unit in Omaha, Neb. Prior to joining ICON, Marion was principal investigator at MDS Pharma Services.

CRO Health Decisions hired Craig Hurt as its new controller to “prime” the company for growth, according to Health Decisions’ chief financial officer, Alicia Paladin. Hurt, a licensed CPA, will manage all accounting and finance functions, including compliance with GAAP and regulatory authorities, for the CRO. He was formerly senior finance manager at Nortel.

Former INC Research and PPD executive Becky Causey has been named executive vice president of clinical operations for ResearchPoint. In this role, Causey will assist in defining processes and strategic direction for operations for the CRO.